Celeste Decker, MD
BioMarin Pharmaceutical
4
0
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Debra Lounsbury
BioMarin Pharmaceutical
Shared therapeutic areas:
Worked with same sponsors:
Chester B. Whitley, M.D., Ph.D.
University of Minnesota
Shared therapeutic areas:
Ira J Fox, MD
University of Pittsburgh
Shared therapeutic areas:
Anita MacDonald, Professor
Birmingham Children´s Hospital
Shared therapeutic areas:
Tippi C MacKenzie, MD
University of California, San Francisco
Shared therapeutic areas:
K. Scott Baker
Fairview University Medical Center
Shared therapeutic areas:
Lynda E Polgreen, MD, MS
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Shared therapeutic areas:
Mitchell S Cairo, MD
New York Medical College
Shared therapeutic areas:
Ashley Schneider
University of Minnesota
Shared therapeutic areas:
Desiree White, Ph.D.
Washington University School of Medicine
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)
A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
All 4 trials loaded